Back | Next |
home / stock / mbrx / mbrx message board
Subject | By | Source | When |
---|---|---|---|
I cant believe that this message board has | TheSprinx | investorshub | 02/16/2021 2:22:23 AM |
Annamycin is a next-generation anthracycline that has recently | Chemist823 | investorshub | 02/14/2021 4:28:26 PM |
chemist823: Looks like a triple waiting to happen. 100% success rate with cancer drug not to mention | chemist823 | investorshangout | 02/11/2021 8:46:49 PM |
This looks to me to be severely under priced. | Chemist823 | investorshub | 02/11/2021 8:44:07 PM |
whytestocks: $MBRX News Article - Moleculin Announces Full Exercise of Over-Allotment Option | whytestocks | investorshangout | 02/10/2021 9:35:50 PM |
5.70!!!!! | TheSprinx | investorshub | 02/10/2021 12:18:29 PM |
Make it 5.18!!! Lol | TheSprinx | investorshub | 02/09/2021 10:45:02 PM |
Check that $5.15!! | TheSprinx | investorshub | 02/09/2021 9:53:37 PM |
$5.10!! News Eminent | TheSprinx | investorshub | 02/09/2021 8:28:43 PM |
It was there confirmation that they closed. Share | TheSprinx | investorshub | 02/09/2021 7:32:19 PM |
Prolly another R/S | tigertiger88 | investorshub | 02/08/2021 9:39:44 PM |
I smell something great about to Happen! | TheSprinx | investorshub | 02/08/2021 8:34:30 PM |
Sold my shares and deleted from my watchlist | Wolf91 | investorshub | 02/04/2021 2:36:51 PM |
Offering at $4.75. Closes Friday. Time to load | TheSprinx | investorshub | 02/03/2021 7:24:24 PM |
rinse, repeat | tigertiger88 | investorshub | 02/03/2021 3:42:25 PM |
Not looking good today. | Dennisb68 | investorshub | 02/03/2021 2:17:51 PM |
Selling off in AH trading. Down 1/2 of | Dennisb68 | investorshub | 02/03/2021 12:05:56 AM |
* * $MBRX Video Chart 02-02-2021 * * | ClayTrader | investorshub | 02/02/2021 10:59:27 PM |
I sold out right after Waiting for this to | TheSprinx | investorshub | 02/02/2021 9:41:17 PM |
znewcar1: MBRX 35% v53,8M c6.39 f10,4M preMH9.3 S6.77 then ran to HOD8.78 only to fail down | znewcar1 | investorshangout | 02/02/2021 9:38:12 PM |
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML PR Newswire HOUSTON , July 10, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfoli...
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...
Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial PR Newswire – 89% of CRc's were subjects with "poor prognosis" cytogenetics and/or mutations – Current median durability of response (mDOR) of CRc's = 6 months and in...